Updated EU CLP Rules: A Practical Breakdown for Chemical BusinessesThe EU has revised its Classification, Labelling and Packaging (CLP) Regulation again, and...
Learn how the UAE’s transfer of 44 pharmaceutical services from MOHAP to Emirates Drug Establishment impacts product registration, pricing, pharmacovigilance, a…
JFDA PIC/S membership impact on Jordan pharma boosts GMP alignment, reduces inspections, strengthens compliance, exports and global market access.
What FDA and EMA experience doesn't prepare regulatory teams for in a COFEPRIS NCE filing — and why that gap surfaces at the worst possible moment.
Your PV program may have been compliant when you built it. Here's why that's no longer enough — and what COFEPRIS actually evaluates today.
Global biologics dossiers regularly face friction at INVIMA — not because they are incomplete, but because they are not locally interpreted. Learn what dossier …
Learn how pharma companies can meet ALCOA+ data integrity requirements across GMP systems and prepare for global inspections with expert support from Freyr.
Discover how pharma companies can strengthen inspection readiness across GMP, GDP, and GxP operations using proactive audit strategies and sustainable complianc…
Stay compliant with the latest EU CLP Regulation updates. Review hazard classifications, SDS, labeling requirements, and 2028 deadlines.
GMP Harmonization: Aligning Food Safety Standards in a Globalized Supply ChainFood and dietary supplement manufacturers operate under a system known as Good ...
Learn how to prepare for FDA's proposed Front-of-Pack Labeling Rule 2026, including compliance timelines, labeling requirements, and readiness strategies.
Learn how Freyr supports pharmaceutical companies with TGA-compliant dossier preparation, CTD/eCTD submissions, GMP clearance, and ARTG submission readiness in …
Learn what CDSCO reviewers evaluate during India submissions, including CTD dossier quality, Module 1 compliance, query management, and regulatory due diligence…
Discover what the TGA evaluates during ARTG dossier review, common submission gaps, and how dossier due diligence can reduce approval delays for medicinal produ…
What the EU's PPWR FAQ Means for Substances of Concern in PackagingAs the 12 August 2026 application date for the Packaging and Packaging Waste Regulation (R...
An overview of toxicological risk assessment for impurities, residual solvents, elemental impurities, mutagenic impurities, and E&L. Discover Freyr's expertise.
Discover the August 2026 PPWR changes for substances of concern, PFAS, heavy metals, and supplier compliance requirements for packaging.
Explore efficient best practices for managing post-approval labeling changes, safety updates, variation control, and Regulatory submission readiness.
Explore how pharmaceutical companies can manage drug labeling complexity, safety updates, and global compliance across the product lifecycle.
This blog talks about medical devices risk management, highlighting compliance areas, documentation, and ISO 14971 essentials.